Skip to contentT
Tenon Medical, Inc.
T
TNONWTenon Medical, Inc. Q3 2025 · 10-Q
Revenue$1.17M$1.17M+32.2% vs Q3 2024 Net Income-$3.34M-$3.34MN/M vs Q3 2024 EPS Diluted-$0.40-$0.40N/M vs Q3 2024 Gross Profit$773,000+84.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenon Medical, Inc. · CIK 1560293 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,824,000N/M Free Cash Flowderived-$3,713,000N/M Margins · derivedGross margin65.9%+18.8 pt vs Q3 2024
Operating margin-289.2%+73.3 pt vs Q3 2024
Net margin-284.7%+74.3 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 13, 2025 · 44 d after period end